Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Subacute Cutaneous Lupus Erythematosus (SCLE) is a distinct subtype of lupus that primarily affects the skin, causing characteristic rash patterns on sun-exposed areas. While the diagnosis is primarily based on clinical presentation and skin examination, specific blood tests play a crucial role in confirming the diagnosis and understanding the underlying autoimmune activity.
This test detects SS-A and SS-B antibodies in the blood. The presence of SS-A antibodies (particularly anti-Ro52 and anti-Ro60) is strongly associated with Subacute Cutaneous Lupus Erythematosus and is found in approximately 60-70% of patients with this condition. These antibodies help confirm the autoimmune nature of the skin manifestations and can guide treatment decisions.
SCLE is an autoimmune condition where the body's immune system mistakenly attacks healthy skin tissue. Blood tests help identify specific autoantibodies that are commonly associated with this condition, providing valuable diagnostic support and helping healthcare providers distinguish SCLE from other skin conditions or lupus subtypes.
A positive SS-A antibody test, combined with characteristic skin symptoms, strongly supports a diagnosis of SCLE. However, it's important to note that some patients with SCLE may test negative for these antibodies, and the diagnosis ultimately relies on the clinical expertise of a dermatologist or rheumatologist who can evaluate both the laboratory results and physical examination findings.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider, preferably a dermatologist or rheumatologist, for proper diagnosis and treatment of suspected autoimmune skin conditions.